Volume 27, Issue 3 , Pages 289-296, March 2008
Quilty Indicates Increased Risk for Microvasculopathy and Poor Survival After Heart Transplantation
Background
The impact of Quilty (sub-endocardial infiltration of lymphocytes) on the development of stenotic microvasculopathy and outcome after heart transplantation has not yet been evaluated.
Methods
Biopsies (n = 9,713) obtained within the first post-transplant year from 873 patients (722 men, age 49.3 ± 0.3 years) were evaluated by light microscopy (hematoxylin–eosin) for Quilty and cellular rejection (ISHLT), stenotic microvasculopathy (luminal radius:medial thickness ratio <1) and endothelial disease (core diameter:cell diameter ratio ≤1). Risk factors for stenotic microvasculopathy were analyzed by logistic regression. Overall survival and freedom from graft failure (cardiac re-transplantation, myocardial infarction and sudden cardiac death) were estimated by the Kaplan–Meier method and tested using a Cox proportional hazard model.
Results
We found 1,830 (19%) Quilty-positive biopsies in 481 (55%) Quilty-formers and stenotic microvasculopathy in 866 (9%) biopsies of 379 (43%) patients. Evidence of Quilty (odds ratio [OR] 1.77; 95% confidence interval [CI] 1.26 to 2.57) and endothelial disease (OR 4.98; 95% 95% CI 3.31 to 7.49) indicated higher risk, whereas post-transplant statin therapy was associated with lower risk for stenotic microvasculopathy (OR 0.68; 95% CI 0.48 to 0.97). Freedom from graft failure was lower in Quilty-formers (p = 0.0060) and even worse if patients suffered from both Quilty and stenotic microvasculopathy (p = 0.0017). Both factors were confirmed in multivariate regression analysis (stenotic microvasculopathy risk ratio [RR] 1.90, 95% CI 1.23 to 2.95; Quilty RR 1.77, 95% CI 1.11 to 2.82, p = 0.0430).
Conclusions
Presence of Quilty indicates increased risk for stenotic microvasculopathy in biopsy early after heart transplantation. Both are associated with poor outcome due to graft failure.
To access this article, please choose from the options below
Supported by the German Research Foundation, Bonn, Germany (#He 1669/13-1).
PII: S1053-2498(07)01412-X
doi:10.1016/j.healun.2007.11.573
© 2008 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Volume 27, Issue 3 , Pages 289-296, March 2008
